Social Media Press Releases

RSS

Showing Press Releases with Tag: monoclonal antibody

6/29/2006

MedImmune Broadens Efforts to Develop Vaccines to Help Prevent RSV and Other Important Pediatric Respiratory Diseases

» read more
5/22/2006

MedImmune Fills Senior Marketing and Sales Post

» read more
5/04/2006

MedImmune Awarded $170 Million, Five-Year Contract From U.S. Health and Human Services to Develop Cell-Based Influenza Vaccines

» read more
4/20/2006

MedImmune Licenses Elusys Therapeutics’ Technology for Use in Developing New Therapies Targeting Infectious Disease

» read more
4/13/2006

MedImmune Begins Dosing of Lupus Patients in Phase 1 Clinical Trial

» read more
4/10/2006

Additional Preclinical and Clinical Data Indicate Abegrin(TM) May Offer Three-Pronged Approach to Cancer Therapy

» read more
2/27/2006

MedImmune Promotes Smullen to Senior Vice President, Sales

» read more
12/15/2005

MedImmune Completes Enrollment in Phase 3 Study Comparing Numax(TM) to Synagis(R)

» read more
12/14/2005

MedImmune and Biota Announce Collaboration to Develop New Therapies for RSV Infection

» read more
12/08/2005

MedImmune Licensing New Antibody-Enhancing Technologies to Further Strengthen its Development-Stage Pipeline

» read more
12/08/2005

MedImmune Expands Oncology Pipeline with Increased Focus on Eph Proteins as Potential Target for New Cancer Therapies

» read more
11/16/2005

MedImmune to Build New Biologics Manufacturing Facility in Frederick, Maryland

» read more
10/13/2005

MedImmune and Medarex Announce Filing of Investigational New Drug Application for Monoclonal Antibody for the Treatment of Lupus

» read more
9/01/2005

MedImmune’s Phase 1 Numax(TM) Study Shows Potential to Reduce RSV Disease in Upper Airway of Children

» read more
8/31/2005

MedImmune Amends U.S. Co-Promotion Agreement for Synagis(R) With Abbott

» read more